FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1480858785> ?p ?o ?g. }

• W1480858785 abstract "Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CAMGMT (O6-methylguanine-DNA methyltransferase) is an antimutagenic DNA repair protein and an established target for improving chemotherapy with alkylating agents. MGMT is highly expressed in breast cancers. This study investigated whether i) MGMT is modulated by endocrine therapies, ii) MGMT interacts with ER-signaling components and iii) if such findings are exploitable for improved breast cancer treatment. The ER-α positive cell lines MCF-7, T47D and ER- α negative MDAMB 468 cells, all MGMT-proficient, were treated with Fulvestrant (Faslodex, ICI 182, 780) or O6-benzylguanine (BG) in various experiments. Fulvestrant is a pure antiestrogen that binds to ER without eliciting any transcriptional effects, but leads to the receptor degradation through the ubiquitin-proteasome (ub-P) pathway. BG is a specific pseudosubstrate for MGMT currently in clinical trials that inactivate the repair protein resulting in its degradation, again by the ub-P pathway. Fulvestrant (0.1-1 µM) induced a dose- and time-dependent inhibition of MGMT's DNA repair activity with a 75% inhibition after 1 µM treatment at 72 h. Interestingly, western blot analyses showed a progressive loss of both ER-α and MGMT proteins in Fulvestrant -treated cells. The MGMT in ER- α negative MDMAB cells was not affected by the drug. Similarly, BG (20-50 µM) induced a time-dependent significant destruction of the ER- α and MGMT proteins in cells. Immunoprecipitation using antibodies to either MGMT or ER- α followed by western blot analyses showed that the two proteins exist physically associated in breast cancer cells. siRNA and shRNAs specific for MGMT downregulated both the ER- α and MGMT proteins in MCF-7 cells confirming the mutual dependence and maintenance of these two proteins. RT-PCR showed the downregulation of several genes transactivated by ER- α in BG-treated cells. Furthermore, bortezomib, a proteasomal inhibitor stabilized both ER- α and MGMT proteins in cells after Fulvestrant exposure. Temozolomide or BCNU caused a 2-4 fold increased cell killing when combined with Fulvestrant. We postulate that portions of ER- α and MGMT proteins exist as a complex and inhibition of either of them results in co- ubiquitination by the same E3 ligase and marked for elimination. The MGMT-deficiency caused by Fulvestrant warrants the use of alkylating agents with endocrine therapeutics [Supported by grants from CPRIT (RP 130266), NIH RO3 CA125872 and the Association for Research of Childhood Cancer].Citation Format: Kalkunte S. Srivenugopal, Ameya Paranjpe. Specific interaction of human MGMT with ER-α in breast cancer cells: Co-degradation of MGMT and ER- α proteins by either fulvestrant or O6-benzylguanine and its therapeutic significance. [abstract]. In: Proceedings of the 105th Annual Meeting of the American Association for Cancer Research; 2014 Apr 5-9; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2014;74(19 Suppl):Abstract nr 2739. doi:10.1158/1538-7445.AM2014-2739" @default.
• W1480858785 created "2016-06-24" @default.
• W1480858785 creator A5033003394 @default.
• W1480858785 creator A5081835857 @default.
• W1480858785 date "2014-09-30" @default.
• W1480858785 modified "2023-09-25" @default.
• W1480858785 title "Abstract 2739: Specific interaction of human MGMT with ER-α in breast cancer cells: Co-degradation of MGMT and ER- α proteins by either fulvestrant or O6-benzylguanine and its therapeutic significance" @default.
• W1480858785 doi "https://doi.org/10.1158/1538-7445.am2014-2739" @default.
• W1480858785 hasPublicationYear "2014" @default.
• W1480858785 type Work @default.
• W1480858785 sameAs 1480858785 @default.
• W1480858785 citedByCount "0" @default.
• W1480858785 crossrefType "proceedings-article" @default.
• W1480858785 hasAuthorship W1480858785A5033003394 @default.
• W1480858785 hasAuthorship W1480858785A5081835857 @default.
• W1480858785 hasConcept C104317684 @default.
• W1480858785 hasConcept C121608353 @default.
• W1480858785 hasConcept C126322002 @default.
• W1480858785 hasConcept C134459356 @default.
• W1480858785 hasConcept C185592680 @default.
• W1480858785 hasConcept C25602115 @default.
• W1480858785 hasConcept C2776415932 @default.
• W1480858785 hasConcept C2780482068 @default.
• W1480858785 hasConcept C33288867 @default.
• W1480858785 hasConcept C502942594 @default.
• W1480858785 hasConcept C530470458 @default.
• W1480858785 hasConcept C552990157 @default.
• W1480858785 hasConcept C55493867 @default.
• W1480858785 hasConcept C71924100 @default.
• W1480858785 hasConcept C84606932 @default.
• W1480858785 hasConcept C86803240 @default.
• W1480858785 hasConcept C91965660 @default.
• W1480858785 hasConceptScore W1480858785C104317684 @default.
• W1480858785 hasConceptScore W1480858785C121608353 @default.
• W1480858785 hasConceptScore W1480858785C126322002 @default.
• W1480858785 hasConceptScore W1480858785C134459356 @default.
• W1480858785 hasConceptScore W1480858785C185592680 @default.
• W1480858785 hasConceptScore W1480858785C25602115 @default.
• W1480858785 hasConceptScore W1480858785C2776415932 @default.
• W1480858785 hasConceptScore W1480858785C2780482068 @default.
• W1480858785 hasConceptScore W1480858785C33288867 @default.
• W1480858785 hasConceptScore W1480858785C502942594 @default.
• W1480858785 hasConceptScore W1480858785C530470458 @default.
• W1480858785 hasConceptScore W1480858785C552990157 @default.
• W1480858785 hasConceptScore W1480858785C55493867 @default.
• W1480858785 hasConceptScore W1480858785C71924100 @default.
• W1480858785 hasConceptScore W1480858785C84606932 @default.
• W1480858785 hasConceptScore W1480858785C86803240 @default.
• W1480858785 hasConceptScore W1480858785C91965660 @default.
• W1480858785 hasLocation W14808587851 @default.
• W1480858785 hasOpenAccess W1480858785 @default.
• W1480858785 hasPrimaryLocation W14808587851 @default.
• W1480858785 hasRelatedWork W1641274628 @default.
• W1480858785 hasRelatedWork W1975685996 @default.
• W1480858785 hasRelatedWork W1979154472 @default.
• W1480858785 hasRelatedWork W1992740282 @default.
• W1480858785 hasRelatedWork W2012909561 @default.
• W1480858785 hasRelatedWork W2021565116 @default.
• W1480858785 hasRelatedWork W2036061214 @default.
• W1480858785 hasRelatedWork W2078071305 @default.
• W1480858785 hasRelatedWork W2110013163 @default.
• W1480858785 hasRelatedWork W2128910264 @default.
• W1480858785 hasRelatedWork W2553488599 @default.
• W1480858785 hasRelatedWork W2740167058 @default.
• W1480858785 hasRelatedWork W2760429533 @default.
• W1480858785 hasRelatedWork W2785124693 @default.
• W1480858785 hasRelatedWork W2793531790 @default.
• W1480858785 hasRelatedWork W2896535424 @default.
• W1480858785 hasRelatedWork W2945641526 @default.
• W1480858785 hasRelatedWork W3009518676 @default.
• W1480858785 hasRelatedWork W3044598395 @default.
• W1480858785 hasRelatedWork W3083417945 @default.
• W1480858785 isParatext "false" @default.
• W1480858785 isRetracted "false" @default.
• W1480858785 magId "1480858785" @default.
• W1480858785 workType "article" @default.